Ledger.Open graph →
SEC Form D · filed August 12, 2024

Talus Bioscience, Inc

Offering
$11.3M
Sold
$9.4M
Exemption
Rule 506(b)
Industry
Other Technology
Location
Seattle, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

J. S. Strattan · Seattle, WADirectorLindsay Pino · Seattle, WAExec · DirectorMichelle Briscoe · Seattle, WAExecAlex Federation · Seattle, WAExec · Director · PromoterOmri Amirav-Drory · Hod Hasharon, L3DirectorLindsay Pino · Seattle, WAExec · DirectorMichelle Briscoe · Seattle, WAExecAlex Federation · Seattle, WAExec · Director · PromoterOmri Amirav-Drory · San Francisco, CADirectorJ. S. Strattan · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗